![Christoph Broja](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christoph Broja
Direttore/Membro del Consiglio presso Cardior Pharmaceuticals GmbH
Posizioni attive di Christoph Broja
Società | Posizione | Inizio | Fine |
---|---|---|---|
EQT Life Sciences (Munich) | Consulente / Consigliere | 01/09/2022 | - |
Investitore di Private Equity | 01/09/2022 | - | |
Cardior Pharmaceuticals GmbH
![]() Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Direttore/Membro del Consiglio | 01/09/2022 | - |
EQT Life Sciences Group BV
![]() EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Investitore di Private Equity | 01/09/2022 | - |
Storia della carriera di Christoph Broja
Precedenti posizioni note di Christoph Broja
Società | Posizione | Inizio | Fine |
---|---|---|---|
Gurnet Point Capital LLC
![]() Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital LLC (Gurnet Point Capital) is a private equity/venture capital firm founded in 2013 by Fereydoun Firouz. The firm is headquartered in Cambridge, Massachusetts. | Analista di Private Equity | 01/08/2016 | 01/03/2021 |
Investitore di Private Equity | 01/03/2021 | 01/06/2022 | |
Tremeau Pharmaceuticals, Inc.
![]() Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA. | Direttore/Membro del Consiglio | 01/03/2019 | 01/06/2022 |
Franz Haniel & Cie. GmbH
![]() Franz Haniel & Cie. GmbH Investment ManagersFinance Franz Haniel & Cie. GmbH is a Haniel family equity firm. The company was founded in 1756 by Jan Willem Noot and is headquartered in Duisburg, Germany. | Analista di Private Equity | 01/05/2010 | 01/07/2012 |
Formazione di Christoph Broja
Friedrich Schiller University of Jena | Undergraduate Degree |
Statistiche
Distribuzione geografica
Germania | 5 |
Stati Uniti | 3 |
Paesi Bassi | 2 |
Posizioni
Private Equity Investor | 3 |
Director/Board Member | 2 |
Private Equity Analyst | 2 |
Settori
Finance | 5 |
Health Technology | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 6 |
---|---|
Franz Haniel & Cie. GmbH
![]() Franz Haniel & Cie. GmbH Investment ManagersFinance Franz Haniel & Cie. GmbH is a Haniel family equity firm. The company was founded in 1756 by Jan Willem Noot and is headquartered in Duisburg, Germany. | Finance |
Cardior Pharmaceuticals GmbH
![]() Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Health Technology |
Tremeau Pharmaceuticals, Inc.
![]() Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA. | Health Technology |
EQT Life Sciences Group BV
![]() EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Finance |
EQT Life Sciences (Munich) | Finance |
Gurnet Point Capital LLC
![]() Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital LLC (Gurnet Point Capital) is a private equity/venture capital firm founded in 2013 by Fereydoun Firouz. The firm is headquartered in Cambridge, Massachusetts. | Finance |
- Borsa valori
- Insiders
- Christoph Broja
- Esperienza